MEDP · Company research
Medpace Holdings, Inc. Common Stock (MEDP): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
22records availableFinancial Services
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| Don’t Chase Medpace Stock Here Despite Its Strong Technical Momentum - Yahoo Finance | Don’t Chase Medpace Stock Here Despite Its Strong Technical Momentum Yahoo Finance | View source ↗ | Yahoo Finance | Oct 15, 2026 | neutral | 0 | 0.6 |
| Medpace Holdings, Inc. (MEDP) Stock Forecasts - Yahoo! Finance Canada | Medpace Holdings, Inc. (MEDP) Stock Forecasts Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 15, 2026 | neutral | 0 | 0.6 |
| At $166.73 a share, Medpace (MEDP) EVP Susan E. Burwig exercised options for 3,000 shares. - Stock Titan | At $166.73 a share, Medpace (MEDP) EVP Susan E. Burwig exercised options for 3,000 shares. Stock Titan | View source ↗ | Stock Titan | Oct 14, 2026 | neutral | 0 | 0.6 |
| CON vs. MEDP: Which Stock Should Value Investors Buy Now? | In a comparison of two Medical Services stocks, Concentra Group (CON) emerges as the superior value option compared to Medpace (MEDP). CON holds a Zacks Rank of #2 (Buy) with improving earnings outlook and more attractive valuation metrics, including a forward P/E of 22.74 versus MEDP's 34.77, and a PEG ratio of 1.37 versus 2.72. CON also received a Value grade of B compared to MEDP's D grade. | View source ↗ | Zacks Investment Research | Oct 14, 2026 | neutral | 0 | 1 |
| CON vs. MEDP: Which Stock Should Value Investors Buy Now? | In a comparison of two Medical Services stocks, Concentra Group (CON) emerges as the superior value option compared to Medpace (MEDP). CON holds a Zacks Rank of #2 (Buy) with improving earnings outlook and more attractive valuation metrics, including a forward P/E of 22.74 versus MEDP's 34.77, and a PEG ratio of 1.37 versus 2.72. CON also received a Value grade of B compared to MEDP's D grade. | View source ↗ | Zacks Investment Research | Oct 14, 2026 | neutral | 0 | 1 |
| CON vs. MEDP: Which Stock Should Value Investors Buy Now? - Yahoo Finance | CON vs. MEDP: Which Stock Should Value Investors Buy Now? Yahoo Finance | View source ↗ | Yahoo Finance | Oct 14, 2026 | neutral | 0 | 0.6 |
| Medpace (MEDP) Dips More Than Broader Market: What You Should Know | Medpace (MEDP) closed down 1.64% and currently holds a Zacks Rank #3 (Hold) rating. The stock trades at a Forward P/E of 35.35, significantly above the industry average of 17.86, and a PEG ratio of 2.77 versus the industry average of 1.67. While earnings are expected to grow 15.28% next quarter and 14.79% for the full year, the premium valuation suggests limited upside potential in the near term. | View source ↗ | Zacks Investment Research | Oct 13, 2026 | neutral | 0 | 1 |
| Medpace: Strong Execution Faces A High-Growth Bar (NASDAQ:MEDP) - Seeking Alpha | Medpace: Strong Execution Faces A High-Growth Bar (NASDAQ:MEDP) Seeking Alpha | View source ↗ | Seeking Alpha | Oct 13, 2026 | neutral | 0 | 0.6 |
| ADC,MEDP,RTB,CRDO,HDSN,KEYS,NHC,TNC,AOMR,AIAI | Stock Prices | Quote Comparison - Yahoo! Finance Canada | ADC,MEDP,RTB,CRDO,HDSN,KEYS,NHC,TNC,AOMR,AIAI | Stock Prices | Quote Comparison Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 12, 2026 | neutral | 0 | 0.6 |
| At $166.73 per share, Medpace (MEDP) EVP Susan E. Burwig exercises options for 2,000 shares. - Stock Titan | At $166.73 per share, Medpace (MEDP) EVP Susan E. Burwig exercises options for 2,000 shares. Stock Titan | View source ↗ | Stock Titan | Oct 9, 2026 | neutral | 0 | 0.6 |
| Medpace Holdings (NasdaqGS:MEDP) Stock Forecast & Analyst Predictions - Simply Wall Street | Medpace Holdings (NasdaqGS:MEDP) Stock Forecast & Analyst Predictions Simply Wall Street | View source ↗ | Simply Wall Street | Oct 8, 2026 | neutral | 0 | 0.6 |
| Medpace (MEDP) Stock Declines While Market Improves: Some Information for Investors | Medpace stock declined 2.84% on October 6, 2026, underperforming the broader market gains. The company is expected to report earnings on October 21 with projected EPS of $4.45 (up 15.28% YoY) and revenue of $708.75 million (up 7.4% YoY). However, the stock trades at a premium valuation with a Forward P/E of 35.38 versus the industry average of 16.59, and holds a Zacks Rank of #3 (Hold). | View source ↗ | Zacks Investment Research | Oct 6, 2026 | neutral | 0 | 1 |
| Medpace (MEDP) Stock Declines While Market Improves: Some Information for Investors - Yahoo Finance UK | Medpace (MEDP) Stock Declines While Market Improves: Some Information for Investors Yahoo Finance UK | View source ↗ | Yahoo Finance UK | Oct 6, 2026 | neutral | 0 | 0.6 |
| MEDP 261016 530.00C (MEDP261016C530000) Stock Options Chain | Quotes & News - Moomoo | MEDP 261016 530.00C (MEDP261016C530000) Stock Options Chain | Quotes & News Moomoo | View source ↗ | Moomoo | Oct 6, 2026 | neutral | 0 | 0.6 |
| Here’s How Much You Would Have Made Owning Medpace Holdings Stock In The Last 10 Years - Benzinga | Here’s How Much You Would Have Made Owning Medpace Holdings Stock In The Last 10 Years Benzinga | View source ↗ | Benzinga | Oct 6, 2026 | neutral | 0 | 0.6 |
| Medpace (MEDP) Stock Looks Fully Valued After A 210% Run - Simply Wall Street | Medpace (MEDP) Stock Looks Fully Valued After A 210% Run Simply Wall Street | View source ↗ | Simply Wall Street | Oct 2, 2026 | neutral | 0 | 0.6 |
| After a 32-share grant conversion, Medpace (MEDP) director Kraft holds 987 shares directly. - Stock Titan | After a 32-share grant conversion, Medpace (MEDP) director Kraft holds 987 shares directly. Stock Titan | View source ↗ | Stock Titan | Oct 2, 2026 | neutral | 0 | 0.6 |
| Medpace results are due after the close Oct. 21; its call follows next morning - Stock Titan | Medpace results are due after the close Oct. 21; its call follows next morning Stock Titan | View source ↗ | Stock Titan | Sep 22, 2026 | neutral | 0 | 0.6 |
| Medpace Holdings (MEDP) Nears Earnings, Is The Stock Fully Valued? - Yahoo Finance | Medpace Holdings (MEDP) Nears Earnings, Is The Stock Fully Valued? Yahoo Finance | View source ↗ | Yahoo Finance | Sep 21, 2026 | neutral | 0 | 0.6 |
| Medpace (MEDP) Stock May Be 9% Undervalued As Growth Expectations Hold - Yahoo Finance | Medpace (MEDP) Stock May Be 9% Undervalued As Growth Expectations Hold Yahoo Finance | View source ↗ | Yahoo Finance | Aug 17, 2026 | neutral | 0 | 0.6 |
| Why Is Medpace (MEDP) Stock Soaring Today - Yahoo Finance | Why Is Medpace (MEDP) Stock Soaring Today Yahoo Finance | View source ↗ | Yahoo Finance | Jul 23, 2026 | neutral | 0 | 0.6 |
| Medpace (MEDP) Stock Faces Margin Compression That Tests Bullish Growth Narratives - Simply Wall Street | Medpace (MEDP) Stock Faces Margin Compression That Tests Bullish Growth Narratives Simply Wall Street | View source ↗ | Simply Wall Street | Jul 23, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.